Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

2(50%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

25%

Ph not_applicable

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 1Safety & dosage

1(50.0%)

N/ANon-phased studies

1(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Detailed Status

Completed2

Recruiting1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (50.0%)

N/A1 (50.0%)

Trials by Status

recruiting125%

completed250%

active_not_recruiting125%

Recent Activity

2 active trials

Showing 4 of 4

active_not_recruitingnot_applicable

Researching the Effect of Aerobic Exercise on Cancer

NCT03996239

recruiting

Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients

NCT02139020

completed

Pharmacokinetics of Ethionamide and Ethionamide Sulfoxide in Patients Established on Treatment for Tuberculosis.

NCT05258877

completedphase_1

CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas

NCT00323323

Clinical Trials (4)

Showing 4 of 4 trials

NCT03996239Not Applicable

Researching the Effect of Aerobic Exercise on Cancer

Active Not Recruiting

NCT02139020

Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients

Recruiting

NCT05258877

Pharmacokinetics of Ethionamide and Ethionamide Sulfoxide in Patients Established on Treatment for Tuberculosis.

Completed

NCT00323323Phase 1

CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas

Completed

All 4 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 4